Thus, an increasing number of experiments, both in vivo and in vitro, have proven the role of caspase-1 in cardiovascular disease, and a possible new strategy for their treatment is the use of drugs to inhibit pyroptosis [61]. This evidence concerns the gene CASP1 and cardiovascular disorder.